🚧 En construcción — Los datos pueden ser inexactos. Estamos añadiendo activamente más empresas y métricas.

Vale S.A. vs Takeda Pharmaceutical Company Limited

Comparación de la capitalización de mercado a lo largo del tiempo

Vale S.A.

$58.5B

Puesto #248

Takeda Pharmaceutical Company Limited

$59.0B

Puesto #245

Capitalización de mercado a lo largo del tiempo

Momentos clave

  • Vale S.A. superó a Takeda Pharmaceutical Company Limited para 2007
  • Takeda Pharmaceutical Company Limited superó a Vale S.A. para 2008
  • Vale S.A. superó a Takeda Pharmaceutical Company Limited para 2009
  • Takeda Pharmaceutical Company Limited superó a Vale S.A. para 2013
  • Vale S.A. superó a Takeda Pharmaceutical Company Limited para 2018
  • Takeda Pharmaceutical Company Limited superó a Vale S.A. para 2019
  • Vale S.A. superó a Takeda Pharmaceutical Company Limited para 2020
  • Takeda Pharmaceutical Company Limited superó a Vale S.A. para 2024
  • Vale S.A. superó a Takeda Pharmaceutical Company Limited para 2025
  • Takeda Pharmaceutical Company Limited superó a Vale S.A. para 2026

Comparación año por año

AñoVale S.A.Takeda Pharmaceutical Company LimitedLíder
2026$58.5B$59.0BTakeda Pharmaceutical Company Limited
2025$52.7B$50.3BVale S.A.
2024$33.1B$41.6BTakeda Pharmaceutical Company Limited
2023$54.6B$38.6BVale S.A.
2022$53.5B$37.6BVale S.A.
2021$40.5B$27.3BVale S.A.
2020$41.1B$31.2BVale S.A.
2019$30.3B$34.2BTakeda Pharmaceutical Company Limited
2018$30.2B$28.0BVale S.A.
2017$26.7B$46.8BTakeda Pharmaceutical Company Limited
2016$16.0B$34.2BTakeda Pharmaceutical Company Limited
2015$6.9B$41.4BTakeda Pharmaceutical Company Limited
2014$16.3B$33.1BTakeda Pharmaceutical Company Limited
2013$29.1B$30.8BTakeda Pharmaceutical Company Limited
2012$38.0B$23.7BVale S.A.
2011$36.7B$19.8BVale S.A.
2010$55.6B$22.3BVale S.A.
2009$45.9B$20.5BVale S.A.
2008$18.7B$23.7BTakeda Pharmaceutical Company Limited
2007$49.0B$32.5BVale S.A.
2006$22.0B$39.6BTakeda Pharmaceutical Company Limited
2005$14.9B$30.4BTakeda Pharmaceutical Company Limited
2004$10.2B$24.2BTakeda Pharmaceutical Company Limited
2003$6.6B$19.6BTakeda Pharmaceutical Company Limited
2002$3.1B$22.5BTakeda Pharmaceutical Company Limited